Tatva Chintan Pharma Chem Limited
NSE:TATVA.NS
856.35 (INR) • At close November 4, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 834.9 | 1,054.64 | 982.66 | 842.06 | 966.69 | 1,143.64 | 1,245.12 | 1,206.07 | 900.91 | 884.02 | 961.76 | 1,046.7 | 1,236.15 | 1,068.32 | 1,051.65 | 801.17 | 600.43 | 515.32 |
Kosten van de omzet
| 427.21 | 763.59 | 620.77 | 373.42 | 373.14 | 580.48 | 750.08 | 677.97 | 434.46 | 398.5 | 542.76 | 451.86 | 550.1 | 532.06 | 634.76 | 321.25 | 336.12 | 262.53 |
Brutowinst
| 407.69 | 291.05 | 361.89 | 468.64 | 593.55 | 563.16 | 495.04 | 528.1 | 466.45 | 485.52 | 419 | 594.84 | 686.05 | 536.26 | 416.89 | 479.92 | 264.31 | 252.79 |
Brutowinstmarge
| 0.488 | 0.276 | 0.368 | 0.557 | 0.614 | 0.492 | 0.398 | 0.438 | 0.518 | 0.549 | 0.436 | 0.568 | 0.555 | 0.502 | 0.396 | 0.599 | 0.44 | 0.491 |
Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 60.39 | 0 | 0 | 0 | 37.07 | 0 | 0 | 0 | 7.04 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verkoop-, algemene en administratieve kosten
| 222.43 | 231.55 | 268.13 | 211.04 | 140.69 | 115.62 | 229.02 | 244.02 | 262.72 | 85.81 | 91.54 | 82.23 | 74.54 | 206.67 | 68.69 | 71.18 | 53.6 | 47.59 |
Overige kosten
| 419.95 | 11.73 | 45.28 | 12.1 | 7.56 | 10.15 | 8.45 | 15.2 | 15.49 | 18.29 | -91.6 | 47.24 | 28.04 | 13.22 | -28.92 | 6.55 | 19.48 | 0 |
Bedrijfskosten
| 419.95 | 231.55 | 268.13 | 424.53 | 458.84 | 409.85 | 357.57 | 372.8 | 377.76 | 356.69 | 206.1 | 377.52 | 347.68 | 292.48 | 173.64 | 250.61 | 217.48 | 164.48 |
Bedrijfsresultaat
| -12.26 | 59.5 | 93.76 | 56.21 | 134.71 | 153.31 | 145.92 | 170.5 | 104.18 | 128.83 | 209.81 | 217.32 | 338.37 | 257 | 250.62 | 235.84 | 66.31 | 86.63 |
Bedrijfsresultaat ratio
| -0.015 | 0.056 | 0.095 | 0.067 | 0.139 | 0.134 | 0.117 | 0.141 | 0.116 | 0.146 | 0.218 | 0.208 | 0.274 | 0.241 | 0.238 | 0.294 | 0.11 | 0.168 |
Totaal overige inkomsten en kosten netto
| 2.05 | 8.59 | 43.14 | -3.77 | -22.58 | -19.11 | -67.86 | -28.27 | -13.6 | 8.12 | -20.05 | 37.36 | 15.8 | -14.39 | -8.23 | -11.09 | -9.87 | -3.27 |
Inkomen voor belasting
| -10.21 | 68.09 | 136.9 | 52.44 | 112.13 | 134.2 | 78.06 | 142.23 | 90.58 | 136.95 | 189.76 | 254.68 | 354.17 | 242.61 | 242.39 | 224.75 | 56.44 | 83.36 |
Inkomen voor belasting ratio
| -0.012 | 0.065 | 0.139 | 0.062 | 0.116 | 0.117 | 0.063 | 0.118 | 0.101 | 0.155 | 0.197 | 0.243 | 0.287 | 0.227 | 0.23 | 0.281 | 0.094 | 0.162 |
Belastingkosten
| -3.57 | 16 | 40.76 | 17.89 | 34.32 | 39.16 | -91.53 | 26 | 19.46 | 38.98 | 14.66 | 26.61 | 30.05 | 11.15 | 31.2 | 16 | 20.88 | 16.26 |
Nettowinst
| -6.64 | 52.09 | 96.14 | 34.55 | 77.81 | 95.04 | 169.59 | 116.23 | 71.12 | 97.97 | 175.1 | 228.07 | 324.12 | 231.46 | 211.19 | 208.75 | 35.56 | 67.1 |
Nettowinstmarge
| -0.008 | 0.049 | 0.098 | 0.041 | 0.08 | 0.083 | 0.136 | 0.096 | 0.079 | 0.111 | 0.182 | 0.218 | 0.262 | 0.217 | 0.201 | 0.261 | 0.059 | 0.13 |
WPA (Winst Per Aandeel)
| -0.29 | 2.23 | 4.11 | 1.48 | 3.43 | 4.29 | 7.65 | 5.24 | 3.21 | 4.42 | 7.9 | 10.29 | 15.02 | 10.44 | 10.51 | 10.39 | 1.77 | 3.34 |
Verwaterde WPA
| -0.29 | 2.23 | 4.11 | 1.48 | 3.43 | 4.29 | 7.65 | 5.24 | 3.21 | 4.42 | 7.9 | 10.29 | 15.02 | 10.44 | 10.51 | 10.39 | 1.77 | 3.34 |
EBITDA
| 59.64 | 126.15 | 156.09 | 122.04 | 210.04 | 223.58 | 171.23 | 194.33 | 127.26 | 170.45 | 217.06 | 285.32 | 386.98 | 275.98 | 268.37 | 251.75 | 83.15 | 97.878 |
EBITDA ratio
| 0.071 | 0.12 | 0.159 | 0.145 | 0.217 | 0.195 | 0.138 | 0.161 | 0.141 | 0.193 | 0.226 | 0.273 | 0.313 | 0.258 | 0.255 | 0.314 | 0.138 | 0.19 |